JP Morgan Maintains Neutral on Amgen, Raises Price Target to $425
Benzinga Newsdesk 6 hours ago
Analyst RatingsNewsPrice TargetHot
JP Morgan analyst Chris Schott maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $350 to $425.
JP Morgan analyst Chris Schott maintains Amgen (NASDAQ:AMGN) with a Neutral and raises the price target from $350 to $425.